TECHNOLOGICAL SOLUTION

TECHNOLOGICAL SOLUTION

The AGS technology brings to market a new system of dry
granulation through a machine that allows drug manufacturers
to effectively formulate any drug.

Discover more
TECHNICAL ADVANTAGES

TECHNICAL ADVANTAGES

The AGS technology offers pharmaceutical manufacturers
(or CMOs providing an outsourcing service) a very quick and
effective solution to find the appropriate drug formulation.

Discover more
BENEFITS FOR CUSTOMERS

BENEFITS FOR CUSTOMERS

  • Reduced production costs
  • Simplified and optimized production cycle
  • Extension of existing products patent life (line-extension) and creation of super-generic products
  • Substantial enhancement of existing drugs
  • Introduction of new drugs

Discover more
/ 3 / 3

AGGRADE: Dry Granulation in a Gas Stream

Innovative Technology

The Aerodynamic Granulation System (AGS) is an innovative, world-wide patented technology for the efficient production by dry granulation of rational formulations of pharmaceuticals and nutraceuticals.

A New Standard

AGS has set new standards in the pharmaceutical and nutraceutical manufacturing process: much faster, less expensive, more effective, more versatile and more eco-friendly than any other conventional, present granulation method.

Mission

Our mission is to offer innovative tools for improving manufacturing standards to result in a number of advantages with respect to: • production costs of current systems, • possibility to process substances exhibiting poor solubility with the aim of improving their bioavailability.

THE AGS PILOT PLANT

h

This is the AGS Pilot Plant, located at the Pharmaceutical Technology Dept of the Helsinki University (Finland).

h

Since January 2015 the AGS Pilot Plant was successfully used for the preparation of dozen new formulations of pharmaceutical and nutraceutical products.

h
  1. the AGS pilot system has given excellent results with a very high number of successful formulations.